Injectsense

Injectsense

Measuring and monitoring therapy effectiveness through miniaturized, autonomous in-vivo sensing and data control. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
€45m (Public information from Nov 2023)
Emeryville California (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
USD202120222023
Revenues1.2m1.2m1.1m
% growth--(7 %)
  • Edit
DateInvestorsAmountRound
N/A

$9.8m

Early VC
N/A

$3.4m

Series B
*

$1.7m

Grant
*
N/A

$2.5m

Valuation: $49.0m

Late VC
Total Funding€15.8m

Recent News about Injectsense

Edit
More about Injectsenseinfo icon
Edit

Injectsense operates at the intersection of advanced semiconductor technology and medical systems, specializing in the development of implantable sensors for continuous medical monitoring. The company's core product is a high-value, miniaturized device that provides reliable, precise, and continuous data transmission to help physicians determine the best course of treatment. Injectsense serves healthcare providers and medical institutions, focusing on improving disease outcomes through evidence-supported therapies. The company partners with major strategic players in the medical field to enhance its technology and expand its market reach. Injectsense's business model revolves around the sale and support of its implantable devices, generating revenue through direct sales and strategic partnerships. The company operates primarily in the medical technology market and aims to change the standard of care with its innovative solutions.

Keywords: implantable sensors, semiconductor technology, medical monitoring, continuous data, precision, healthcare, disease outcomes, strategic partnerships, medical devices, innovation.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.